Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9173 USD | -12.64% | -23.56% | +66.78% |
May. 14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XILIO THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -12.64% | -23.56% | +66.78% | -69.92% | - | 38.75M |
Technical Rankings Surperformance
- Stock Market
- Equities
- XLO Stock
- Charts Xilio Therapeutics, Inc.
- Comparison Chart